Helen hails from a town in the heart of Ireland. She undertook a bachelor’s degree in general science at University College Dublin, Ireland, graduating with a joint major in pharmacology and physiology. She worked as an associate scientist with Charles River Laboratories, UK before deciding to take a career break to travel. She eventually circled back into the world of science and completed her master’s degree in biomedical science at the National University of Ireland, Galway, where she became particularily interested in the field of tissue engineering and regenerative medicine. For her research thesis, she investigated fabricating 3D microstructures within a cell encapsulating fibrin gel using two-photon polymerisation. Helen returned to industry to work at Evotec SE, Germany, however she was determined to continue working on developing advanced models of human physiology. This led Helen to join the SINERGIA project (Marie Skłodowska-Curie ITN) as a PhD candidate at the MERLN Institute, where she will focus on developing a kidney model for drug safety screening, using iPSCs and advanced bioprinting technology.